Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,489
Total Claims
$1.0M
Drug Cost
503
Beneficiaries
$2,080
Cost/Patient
Risk Score Breakdown 24/100
Score components are additive. Read full methodology
Peer Comparison vs. 44,021 Emergency Medicine providers
-72%
Opioid rate vs peers
2.7% vs 9.4% avg
+933%
Brand preference vs peers
15.3% vs 1.5% avg
⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
2.7%
Opioid Rate
254
Opioid Claims
$5,293
Opioid Cost
5.1%
Long-Acting Rate
Brand vs Generic
Brand: 1,427 claims · $880K
Generic: 7,885 claims · $160K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 143 | $127K |
| Dulaglutide | 57 | $75K |
| Sitagliptin Phosphate | 67 | $68K |
| Insulin Glargine,hum.Rec.Anlog | 59 | $43K |
| Semaglutide | 26 | $40K |
| Mirabegron | 28 | $28K |
| Rivaroxaban | 40 | $27K |
| Empagliflozin | 15 | $27K |
| Tirzepatide | 22 | $27K |
| Fluticasone/Umeclidin/Vilanter | 25 | $25K |
| Insulin Aspart | 26 | $24K |
| Insulin Glargine,hum.Rec.Anlog | 18 | $23K |
| Umeclidinium Bromide | 41 | $21K |
| Fluticasone/Vilanterol | 36 | $17K |
| Insulin Aspart | 25 | $15K |
Prescribing Profile
Patient Profile
72
Avg Age
55%
Female
1.99
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data